According to brain experts, cannabis has shown considerable promise for treating the cause of dementia and Alzheimer’s, but federal regulators keep blocking their path toward a cure.
Despite evidence suggesting that chemicals found in cannabis can helpfully clear the brain of buildup that leads to dementia and Alzheimer’s disease, ongoing federal opposition to the drug makes the road to finding a cure a long and difficult one, according to researchers. As the Independent reports, scientists at California’s renowned Salk Institute are expressing concern over the fairly unfounded legal hurdles that keep slowing down their work toward an effective treatment for these fatal diseases, which afflict millions of Americans each year.
Last year, the team published study results indicating that the active chemicals or cannabinoids found in cannabis, such as euphoria-inducing tetrahydrocannabinol (THC), can effectively relieve the amyloid protein buildup and cell damage related to dementia using some of the brain’s own protective measures. Unlike methods which seek to remove amyloid buildup from the outside of brain cells, CNBC explained, those explored by Salk researchers work with the brain’s natural endocannabanoids, which prevent cell death, to fight buildup inside cells and resulting inflammation at an earlier stage in the disease.
–Read the entire article here